Strides acquires identified ANDAs from Nostrum Laboratories, USA
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
The portfolio consists of liquids and immediate release solid orals which are in the therapeutic segment to treat infections associated with UTIs
Over the last 24 years, the company's sales has grown from Rs. 478 crores to Rs. 19,022 crores
This recertification of Company's OECD GLP is testimony to company's unwavering commitment to maintain international quality standards at the facility
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
ekincare has raised a total funding of $22M since 2015 till date
Distribution agreement enables FUJIFILM India to offer Spectra Logic advanced tape libraries and software solutions to enterprise customers and channel partners
Bayer expects 2025 to be the most difficult year of its turnaround
The implementation, spearheaded by Deloitte Consulting, brings together domain expertise and cutting-edge technology
A new weapon in the global fight against malaria
Subscribe To Our Newsletter & Stay Updated